Drugmakers need to focus on how a drug improves total patient health


In an article in Managed Care, Jeremy Schafer discusses the findings from a recent breast cancer study reported in JAMA. The results help to validate that emerging drug therapies have played an important role in the declining mortality rates. However, health care stakeholders need to encourage utilization of treatments to deliver the best outcomes.

To read the full article, please click here.


Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.